(19)
(11) EP 1 841 452 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
11.06.2014 Bulletin 2014/24

(45) Mention of the grant of the patent:
02.04.2014 Bulletin 2014/14

(21) Application number: 05789778.7

(22) Date of filing: 07.10.2005
(51) International Patent Classification (IPC): 
A61K 39/395(2006.01)
 C07K 16/28(2006.01)
(86) International application number:
PCT/GB2005/003873
(87) International publication number:
WO 2006/038027 (13.04.2006 Gazette 2006/15)

(54)

SINGLE DOMAIN ANTIBODIES AGAINST TNFR1 AND METHODS OF USE THEREFOR

EINZEL-DOMÄN ANTIKÖRPER GEGEN TNFR1 UND VERFAHREN UND DEREN VERWENDUNGEN

ANTICORPS A DOMAINE UNIQUE CONTRE LE TNFR1 ET PROCEDES ET LEUR UTILISATIONS

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
Designated Extension States:
HR

(30) Priority: 08.10.2004 WO PCT/GB2004/004253
10.11.2004 US 985847

(43) Date of publication of application:
10.10.2007 Bulletin 2007/41

(60) Divisional application:
10182954.7 / 2371390

(73) Proprietor: Domantis Limited
Brentford Middlesex TW8 9GS (GB)

(72) Inventors:
  • BREWIS, Neil, D.
    Cambridge CB4 0WG (GB)
  • WOOLVEN, Benjamin, P.
    Cambridge CB4 0WG (GB)
  • HOLMES, Steve
    Cambridge CB4 0WG (GB)
  • TOMLINSON, Ian, M.
    Cambridge CB4 0WG (GB)
  • LEE, Jennifer
    Cambridge CB4 0WG (GB)
  • ENEVER, Carolyn
    Cambridge CB4 0WG (GB)
  • BASRAN, Amrik
    Cambridge CB4 0WG (GB)
  • JONES, Kate
    Cambridge CB4 0WG (GB)
  • WILDT, Ruud de
    Cambridge CB4 0WG (GB)
  • BLEIN, Stanislas, Charles
    Cambridge CB4 0WG (GB)

(74) Representative: Clube, Jasper Rupert 
GlaxoSmithKline Global Patents (CN925.1) 980 Great West Road
Brentford, Middlesex TW8 9GS
Brentford, Middlesex TW8 9GS (GB)


(56) References cited: : 
WO-A-2004/101790
WO-A2-2004/003019
WO-A2-2004/081026
 WO-A-2005/035572
WO-A2-2004/058821
   
     
    Remarks:
    The file contains technical information submitted after the application was filed and not included in this specification
     
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).